CUA Educational Content

Genetic Testing for Prostate Cancer

Webinar Recording from April 26, 2023

Speakers: Ricardo Rendon, Michael Kolinsky, Shamini Selvarajah

Objectives:

  • Explain how the results of genetic testing in patients with prostate cancer can influence treatment decisions
  • Recognize patients for whom genetic testing should be ordered
  • Describe the familial cancer risks of hereditary gene alterations in patients with prostate cancer
  • Integrate genetic testing for patients with prostate cancer into their clinical practice
Start Quiz for Credits

ACCREDITATION

This activity is an Accredited Self-Assessment Program (Section 3) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and approved by CUA. You may claim a maximum of 1 hour of credit.

 

This program has received financial support from AstraZeneca / /Merck in the form of an educational grant.

The Canadian Urological Association (CUA) does not provide professional medical advice, diagnosis or treatment and cannot respond to requests for direct feedback, specific patient information or physician referrals. You should first always seek the advice of your urologist, physician and other qualified health provider with any questions regarding your medical condition. The contents of the CUA Website such as text, graphics, images, and other content are for informational purposes only. The content/information is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on the CUA website.

For comments or information, email Corporate.office@cua.org

Privacy Policy